Latest newsPapers
An Unfolding Story: The Emerging Picture of the Value of New Medical Technology
Submitted by pragmedicljb on Tue, 08/11/2011 - 20:48
In this European Health Technology Institute research brief, Professor Brian D Smith looks at the value of innovative medical technology and how research has uncovered a clear pattern in health economics.
Six Lessons for Knowledge Based Marketers
Submitted by pragmedicljb on Tue, 08/11/2011 - 20:39
Professor Brian D Smith describes how marketing in knowledge-based industries is different from other businesses.
Improving HTA in Medical Technology: Six Goals for Constructive Engagement
Submitted by pragmedicljb on Fri, 19/08/2011 - 05:31
In this European Health Technology Institute research brief, Professor Brian D Smith looks at how Medical technology companies need to help health technology assessment processes become better at identifying real value.
The Road Ahead
Submitted by pragmedicljb on Sun, 31/07/2011 - 21:36
Our strategy for the future is dependent on what has happened in the past. This article looks at how path dependency theory can help us do a better job of creating strong marketing strategies.
Turf Wars: what the intraorganisational conflict literature may contribute to our understanding of marketing strategy implementation
Submitted by pragmedicljb on Sun, 31/07/2011 - 21:34
The problem of strategy non-implementation is important and complex but poorly understood. This paper published in the Journal of Strategic Marketing explores the explanatory value of theories regarding intraorganisational conflict. It concludes that certain concepts from this area, when augmented with ideas from the social psychology literature and empirical observations of marketing’s interface with other functions, help our understanding of marketing strategy implementation. This may form the basis of future work towards improving the understanding and management of strategy implementation.
Survival Instincts
Submitted by pragmedicljb on Sun, 24/07/2011 - 12:25
Changes in pharma’s market environment will drive the extinction of current business models and the evolution of new ones. What will pharma companies have to do to survive and thrive in this new world? This third in a series of three articles looks at the decisions that the pharmaceutical industry’s leaders face.
Fierce Creatures
Submitted by pragmedicljb on Sun, 24/07/2011 - 12:24
Changes in the social and technological environments are radically reshaping pharma’s competitive landscape, driving the extinction of current business models and the evolution of new ones. But what will those new business models look like? This second in a series of three articles looks at the new creatures that will emerge to populate the pharma market of the future.
Evolutionary Theory
Submitted by pragmedicljb on Sun, 24/07/2011 - 12:22
The global pharmaceutical industry is on the brink of huge change, squeezed between what science makes possible and economics makes practical. But what might that change be? If this industry is to continue to make its huge contribution to society, more than speculation and informed guesswork is required; this knowledge-based industry needs to apply science to understanding its own fate. This first in a series of three articles looks at the future for pharma and what that prediction implies.
JMM Research Watch Vol 11.2
Submitted by pragmedicljb on Mon, 25/04/2011 - 21:14
A selection of research drawn from a special issue of the Journal of Marketing Management, focussed on Value Marketing in the Health Care Industry.
JMM Research Watch Vol 11.1
Submitted by pragmedicljb on Mon, 25/04/2011 - 21:13
This selection of research covers the topics of CSR, price regulation and generic competition.